Pancreatic Cancer: Advances in Treatment
I presented on the topic of advances in treatment of pancreatic cancer a few weeks ago in a talk that went well over an hour and a half. The aim was to give a very broad overview that touched on all the major points but I purposely left out the molecular pathogenesis (K-ras, EGF family, CDKN2A, P53, DPC4, BRCA, STK11, MLH1, MSH2, Sonic Hedgehog (SHH) signaling pathway, etc) because of time. Those are all very important molecules involved in critical pathways because of the potential for screening, early detection, and possibly (someday) treatment. The PowerPoint presentation below won’t be very useful as a learning resource on its own without my speaking notes. I’ll consider putting those up if I get a chance to clean them up. In the mean time, if academically inclined, the references section (last 3 slides) has a list of excellent papers and resources I consulted to put this together.

